Patents by Inventor Stefan Riedmueller
Stefan Riedmueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11958819Abstract: The present invention relates to copolymers, particularly to copolymers comprising a photoactive unit, the copolymers being particularly suitable for ophthalmic devices. The copolymers include one or more different polymer units in addition to the photoactive unit, such as polymerized units derived from ethylene, propylene, an acrylate, a methacrylate, or a styrene.Type: GrantFiled: July 30, 2021Date of Patent: April 16, 2024Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11753387Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.Type: GrantFiled: February 14, 2018Date of Patent: September 12, 2023Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11702396Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.Type: GrantFiled: February 14, 2018Date of Patent: July 18, 2023Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11359031Abstract: The present invention relates to a composition for ophthalmological products, to corresponding copolymers and the preparation thereof and to the use thereof for the production of ophthalmic lenses or ophthalmological implants and to these products.Type: GrantFiled: December 18, 2018Date of Patent: June 14, 2022Assignee: Johnson & Johnson Surgical Vision, Inc.Inventors: Lars Dobelmann-Mara, Simon Helmstetter, Stefan Riedmueller, Martin Schraub
-
Patent number: 11111226Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.Type: GrantFiled: May 7, 2020Date of Patent: September 7, 2021Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11078177Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.Type: GrantFiled: September 4, 2019Date of Patent: August 3, 2021Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11040990Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.Type: GrantFiled: February 14, 2018Date of Patent: June 22, 2021Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11014901Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.Type: GrantFiled: February 14, 2018Date of Patent: May 25, 2021Assignee: Merck Patent GmbHInventors: Martin Schraub, Lars Dobelmann-Mara, Stefan Riedmueller
-
Patent number: 11014900Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.Type: GrantFiled: February 14, 2018Date of Patent: May 25, 2021Assignee: MERCK PATENT GMBHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 11001576Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for compositions and ophthalmic devices as well as to compositions and ophthalmic devices comprising such compounds.Type: GrantFiled: February 14, 2018Date of Patent: May 11, 2021Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 10829451Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.Type: GrantFiled: August 3, 2016Date of Patent: November 10, 2020Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 10723713Abstract: The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds.Type: GrantFiled: August 3, 2016Date of Patent: July 28, 2020Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Publication number: 20190389829Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.Type: ApplicationFiled: September 4, 2019Publication date: December 26, 2019Applicant: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 10457658Abstract: The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.Type: GrantFiled: August 3, 2016Date of Patent: October 29, 2019Assignee: Merck Patent GmbHInventors: Lars Dobelmann-Mara, Stefan Riedmueller, Martin Schraub
-
Patent number: 10439145Abstract: The present invention relates to compounds which are suitable for use in electronic devices, preferably organic electroluminescent devices.Type: GrantFiled: August 6, 2013Date of Patent: October 8, 2019Assignee: Merck Patent GmbHInventors: Holger Heil, Lara-Isabel Rodriguez, Fabrice Eckes, Oliver Kaufhold, Anja Gerhard, Stefan Riedmueller
-
Publication number: 20190002417Abstract: The present invention relates to compounds according to formula (I), which are suitable for use in electronic devices, preferably organic electroluminescent devices.Type: ApplicationFiled: November 28, 2016Publication date: January 3, 2019Applicant: Merck Patent GmbHInventors: Stefan Riedmueller, Oliver Kaufhold, Sebastian Meyer
-
Patent number: 9499474Abstract: The invention relates to a process for producing compounds containing at least one arylamino group by means of a coupling reaction of an amino compound with an aryl compound, using a strong base.Type: GrantFiled: October 19, 2012Date of Patent: November 22, 2016Assignee: Merck Patent GmbHInventors: Oliver Kaufhold, Hubert Spreitzer, Stefan Riedmueller
-
Publication number: 20150255720Abstract: The present invention relates to compounds which are suitable for use in electronic devices, preferably organic electroluminescent devices.Type: ApplicationFiled: August 6, 2013Publication date: September 10, 2015Applicant: Merck Patent GmbHInventors: Holger Heil, Lara-Isabel Rodriguez, Fabrice Eckes, Oliver Kaufhold, Anja Gerhard, Stefan Riedmueller
-
Publication number: 20140309458Abstract: The invention relates to a process for producing compounds containing at least one arylamino group by means of a coupling reaction of an amino compound with an aryl compound, using a strong base.Type: ApplicationFiled: October 19, 2012Publication date: October 16, 2014Applicant: MERCK PATENT GMBHInventors: Oliver Kaufhold, Hubert Spreitzer, Stefan Riedmueller
